Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 70771-1869

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 70771-1869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (D420c4fa 5ed7 412f 8c97 08164c7f6d00 01)

Chemical structure diagram of sitagliptin, showing its molecular components including trifluoromethyl and piperazine rings, corresponding to the active ingredient sitagliptin in the combination drug sitagliptin and metformin hydrochloride.*

FDA Label Image

Structure (D420c4fa 5ed7 412f 8c97 08164c7f6d00 02)

Chemical structure of sitagliptin as shown, including labeled atoms and the hydrochloride salt (HCl). The diagram illustrates the molecular connectivity for sitagliptin hydrochloride used in the combination tablet with metformin hydrochloride.*

FDA Label Image

Graph (D420c4fa 5ed7 412f 8c97 08164c7f6d00 03)

A line graph showing least squares mean change from baseline over 24 weeks for various treatments including placebo, metformin 1000 mg twice daily, sitagliptin 100 mg once daily, sitagliptin 50 mg once daily combined with metformin 500 mg twice daily, and sitagliptin 50 mg once daily combined with metformin 1000 mg twice daily.*

FDA Label Image

Graph (D420c4fa 5ed7 412f 8c97 08164c7f6d00 04)

A line graph comparing the least squares mean change from baseline over 52 weeks for Sitagliptin 100 mg and Glipizide. The x-axis shows weeks, and the y-axis shows change values, illustrating trend lines for both drugs throughout the study duration.*

FDA Label Image

Label (D420c4fa 5ed7 412f 8c97 08164c7f6d00 05)

Label for Sitagliptin and Metformin Hydrochloride tablets, film-coated oral dosage form combining 50 mg Sitagliptin and 500 mg Metformin Hydrochloride. Package contains 60 tablets, labeled Rx only, manufactured by Zydus Lifesciences Ltd. Includes storage instructions, dosage note, and medication guide information. NDC code 70771-1869-6 visible with barcode.*

FDA Label Image

Label (D420c4fa 5ed7 412f 8c97 08164c7f6d00 06)

Packaging label for Sitagliptin and Metformin Hydrochloride Tablets, 50 mg/1,000 mg strength. The label shows that the product is film-coated tablets supplied in a package containing 60 tablets. It is manufactured by Zydus Lifesciences Limited in Ahmedabad, India. The label contains storage instructions, dosage form details, and a barcode, with a clear indication that the product is prescription only (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.